tiprankstipranks
Advertisement
Advertisement

RDHL Stock Latest News

RedHill Biopharma advancing opaganib options for Ebola outbreak biodefense
The FlyRedHill Biopharma advancing opaganib options for Ebola outbreak biodefense
1d ago
RDHL
RedHill Biopharma Moves to Advance Opaganib as Oral Antiviral Option for Current Ebola Outbreak
PremiumCompany Announcements
RedHill Biopharma Moves to Advance Opaganib as Oral Antiviral Option for Current Ebola Outbreak
1d ago
6K
RDHL
RedHill Biopharma Expands At-The-Market ADS Offering to Boost Capital Flexibility
PremiumCompany Announcements
RedHill Biopharma Expands At-The-Market ADS Offering to Boost Capital Flexibility
7d ago
6K
RDHL
RedHill Biopharma Reports Promising MAP-Killing Data for Next-Generation Crohn’s Candidate RHB-204
PremiumCompany Announcements
RedHill Biopharma Reports Promising MAP-Killing Data for Next-Generation Crohn’s Candidate RHB-204
1M ago
6K
RDHL
RedHill Biopharma’s RHB-204 shows efficacy in Crohn’s Disease
PremiumThe Fly
RedHill Biopharma’s RHB-204 shows efficacy in Crohn’s Disease
1M ago
RDHL
RedHill Biopharma Reshapes Talicia Franchise and Strengthens Balance Sheet in 2025 Results
PremiumCompany AnnouncementsRedHill Biopharma Reshapes Talicia Franchise and Strengthens Balance Sheet in 2025 Results
1M ago
6K
RDHL
RedHill Biopharma announces presentation of preclinical data on opaganib at AACR
Premium
The Fly
RedHill Biopharma announces presentation of preclinical data on opaganib at AACR
1M ago
RDHL
RedHill Biopharma Showcases New Opaganib Preclinical Data in Neuroblastoma and Triple-Negative Breast Cancer at AACR 2026
Premium
Company Announcements
RedHill Biopharma Showcases New Opaganib Preclinical Data in Neuroblastoma and Triple-Negative Breast Cancer at AACR 2026
1M ago
6K
RDHL
RedHill Biopharma Receives Nasdaq Minimum Bid Price Deficiency Notice
PremiumCompany Announcements
RedHill Biopharma Receives Nasdaq Minimum Bid Price Deficiency Notice
2M ago
6K
RDHL
RedHill Biopharma Shareholders Approve RSU Grants and Share Capital Increase
PremiumCompany Announcements
RedHill Biopharma Shareholders Approve RSU Grants and Share Capital Increase
3M ago
6K
RDHL
RedHill and Cumberland Begin Joint U.S. Commercial Launch of Talicia
PremiumCompany Announcements
RedHill and Cumberland Begin Joint U.S. Commercial Launch of Talicia
3M ago
6K
RDHL
RedHill Biopharma announces full sales and operational launch of Talicia
PremiumThe Fly
RedHill Biopharma announces full sales and operational launch of Talicia
3M ago
CPIX
RDHL
RedHill Biopharma Calls March 5 Extraordinary Meeting to Approve RSU Grants and Share Capital Increase
PremiumCompany AnnouncementsRedHill Biopharma Calls March 5 Extraordinary Meeting to Approve RSU Grants and Share Capital Increase
4M ago
6K
RDHL
RedHill Biopharma Calls March 5, 2026 Extraordinary Meeting to Approve RSU Grants and Share Capital Increase
Premium
Company Announcements
RedHill Biopharma Calls March 5, 2026 Extraordinary Meeting to Approve RSU Grants and Share Capital Increase
4M ago
6K
RDHL
RedHill Biopharma Advances RHB-102 in GI Indications and GLP-1 Therapy Support
Premium
Company Announcements
RedHill Biopharma Advances RHB-102 in GI Indications and GLP-1 Therapy Support
5M ago
6K
RDHL
RedHill Biopharma announces development progress for RHB-102
PremiumThe Fly
RedHill Biopharma announces development progress for RHB-102
5M ago
RDHL
RedHill Biopharma Files Pro Forma Financials After Talicia Joint Venture Deal With Cumberland
PremiumCompany Announcements
RedHill Biopharma Files Pro Forma Financials After Talicia Joint Venture Deal With Cumberland
5M ago
6K
RDHL
RedHill Biopharma Secures Up to $25 Million Standby Equity Facility with YA II PN
PremiumCompany Announcements
RedHill Biopharma Secures Up to $25 Million Standby Equity Facility with YA II PN
5M ago
6K
RDHL
RedHill Biopharma’s Opaganib Shows Promise in Combating CLL Resistance
PremiumCompany Announcements
RedHill Biopharma’s Opaganib Shows Promise in Combating CLL Resistance
6M ago
6K
RDHL
RedHill Biopharma announces in vivo results on opaganib, venetoclax
PremiumThe FlyRedHill Biopharma announces in vivo results on opaganib, venetoclax
6M ago
RDHL
RedHill Biopharma Regains Nasdaq Compliance
Premium
Company Announcements
RedHill Biopharma Regains Nasdaq Compliance
6M ago
6K
RDHL
RedHill Biopharma regains compliance with Nasdaq equity requirement
Premium
The Fly
RedHill Biopharma regains compliance with Nasdaq equity requirement
6M ago
RDHL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >